Depyrazine 6,8-Dinitro-3-nitroso Varenicline
Also known as: Varenicline Nitrosamine Impurities or nitrosamine impurities of Varenicline| Product Name | Depyrazine 6,8-Dinitro-3-nitroso Varenicline |
|---|---|
| Alternate Names | Varenicline Impurities, Impurities of Varenicline |
| CAT No. | CS-O-44468 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 278.22 g/mol |
| Mol. For. | C11H10N4O5 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Varenicline |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Depyrazine 6,8-Dinitro-3-nitroso Varenicline is a novel chemical compound that has been developed for pharmaceutical use. It is a derivative of Varenicline, which is a medication used to help people quit smoking. Depyrazine 6,8-Dinitro-3-nitroso Varenicline is a potent agonist of nicotinic acetylcholine receptors (nAChRs), which are the primary targets of nicotine in the brain. It has been shown to have a higher affinity for nAChRs than Varenicline, making it a more effective smoking cessation aid.
In addition to its potential use as a smoking cessation medication, Depyrazine 6,8-Dinitro-3-nitroso Varenicline has also been studied for its potential as a treatment for Alzheimer's disease. It has been shown to have neuroprotective effects in animal models of Alzheimer's disease, and it may be able to slow the progression of the disease by reducing inflammation and oxidative stress in the brain.
Chemically, Depyrazine 6,8-Dinitro-3-nitroso Varenicline is a complex molecule that contains two nitro groups and a nitroso group. These chemical groups give the compound its unique properties and make it an effective agonist of nAChRs. The compound is typically synthesized in a laboratory setting using a variety of organic synthesis techniques. Overall, Depyrazine 6,8-Dinitro-3-nitroso Varenicline shows promise as a potential treatment for smoking cessation and Alzheimer's disease, and further research is needed to fully understand its potential therapeutic applications.
Get an Instant Quote
Related Compounds
Varenicline Tartrate Impurity C | Varenicline 1-N-oxide | Varenicline Impurity 5 | Varenicline Metadinitro | Varenicline Impurity 18 | N-nitroso Depyrazine 7,8-Dinitrophenyl Varenicline | Varenicline N-dioxide HCl | Varenicline Monoamino Impurity | VARENICLINE IMPURITY 36 | Varenicline N-Oxide | Varenicline Impurity 25 | Varenicline Impurity 9(N-Nitroso varenicline) | Varenicline Impurity 15 | Varenicline Metadinitro Impurity | Varenicline Impurity 39 | Varenicline Nitroso Impurity 6 | Varenicline Impurity 2 | Varenicline Impurity 6 | Varenicline Impurity | Varenicline Impurity 49 | Varenicline Mononitro Impurity/Impurity | Varenicline Impurity 48 | N-Acetyl Varenicline | bis(6,7,9,10-tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxalin-8-yl)methanone | Varenicline Impurity 17 | Methyl Varenicline | Varenicline Impurity (Hydroxymethyl) | Varenicline Impurity 1 | Varenicline Impurity 13 HCl | Varenicline Impurity 38 | Varenicline Metadiamino HCl impurity | Mono Nitroso Varenicline impurity | VARENICLINE IMPURITY 35 | Varenicline Tartrate Impurity-II | Varenicline N-dioxide | Varenicline Impurity 3 | Varenicline Impurity 4 |